The major core protein P4a (A10L gene) of vaccinia virus is essential for correct assembly of viral DNA into the nucleoprotein complex to form immature viral particles

Journal of Virology

Volumn 75, Issue 13, 2001, Pages 5778-5795

  Heljasvaara, R ^a   Rodriguez D ^a   Risco, C ^a   Carrascosa, J L ^a   Esteban, M ^a   Rodriguez J R ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; GENE PRODUCT; NUCLEOPROTEIN; PROTEIN A10L; PYRANOSIDE; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DNA STRUCTURE; GENE REPRESSION; GENETIC CODE; NONHUMAN; OPERATOR GENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; VACCINIA VIRUS; VIROGENESIS; VIRUS CORE; VIRUS GENE; VIRUS MORPHOGENESIS; VIRUS PARTICLE; VIRUS PLAQUE;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; DNA, VIRAL; HELA CELLS; HUMANS; ISOPROPYL THIOGALACTOSIDE; MOLECULAR SEQUENCE DATA; VACCINIA VIRUS; VIRAL CORE PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 0034979105     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.13.5778-5795.2001     Document Type: Article

References (69)

1. The enzyme-gold cytochemical approach: A review
2. Regulation of vaccinia virus morphogenesis: Phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10 kinase
3. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: Effect of a point mutation in the lectin homology domain of the A34R gene
4. DNA packaging mutant: Repression of the vaccinia virus A32 gene results in noninfectious DNA-deficient spherical, enveloped particles
5. A vaccinia virus core protein, p39, is membrane associated
6. The development of vaccinia virus in Earles L strain cells as examined by electron microscopy
7. Vaccinia as a model for membrane biogenesis
8. Biogenesis of vaccinia: Isolation of conditional lethal mutants and electron microscopy characterization of their phenotypically expressed defects
9. Biology of poxviruses
10. Structure of vaccinia virus late promoters
11. Identification of temperature-sensitive mutants of vaccinia virus that are defective in conversion of concatemeric replicative intermediates to the mature linear DNA genome
12. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans
13. Characterization of ts16, a temperature-sensitive mutant of vaccinia virus
14. Biogenesis of vaccinia: Evidence for more than 100 polypeptides in the virion
15. Defective vaccinia virus particles in interferon-treated infected cells
16. Transient dominant selection of recombinant vaccinia viruses
17. Vectors for the genetic manipulation of African swine fever virus
18. Interruption by rifampin of an early stage in vaccinia virus morphogenesis: Accumulation of membranes which are precursors of virus envelopes
19. De novo synthesis of early transcription factor 70-kilodalton subunit is required for morphogenesis of vaccinia virions
20. Repression of the A8L gene, encoding the early transcription factor 82-kilodalton subunit, inhibits morphogenesis of vaccinia virions
21. Biogenesis of poxviruses: Role of A-type inclusions and host cell membranes in virus dissemination
22. An update on the vaccinia virus genome
23. The preparation and characteristics of highly purified radioactively labelled poxvirus
24. Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the 17 gene that encodes a virion component
25. Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: Inhibition by rifampicin
26. Vaccinia virus structural polypeptide derived from a high-molecular-weight precursor: Formation and integration into virus particles
27. The vaccinia virus II protein is essential for the assembly of mature virions
28. Electron microscopic study of mouse liver infected by ectromelia virus
29. Temperature-sensitive mutations in the gene encoding the small subunit of the vaccinia virus early transcription factor impair promoter binding, transcription activation, and packaging of multiple virions components
30. Resolution of vaccinia virus DNA concatemer junctions requires late-gene expression
31. The insertion of DNA into vaccinia virus
32. Vaccinia virus reexamined: Development and release
33. Poxviridae: The viruses and their replication
34. Protein cleavage and poxvirus morphogenesis: Tryptic peptide analysis of core precursors accumulated by blocking assembly with rifampicin
35. The mechanism of cytoplasmic orthopoxvirus DNA replication
36. Biogenesis of vaccinia: Separation of early stages from maturation by means of rifampicin
37. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia
38. Conditional lethal expression of the vaccinia virus LIR myristylated protein reveals a role in virion assembly
39. Visualization of viral assembly in the infected cell
40. Two types of virus-related particles are found during transmissible gastroenteritis virus morphogenesis
41. The vaccinia virus 39K protein forms a stable complex with the 4a major core protein
42. Regulated expression of nuclear genes by T3 RNA polymerase and lac repressor using recombinant vaccinia virus vectors
43. Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis
44. Inducible expression of vaccinia virus A17L gene provides a synchronized system to follow sorting of viral proteins during morphogenesis
45. Insertional inactivation of vaccinia virus 32K gene is associated with attenuation in mice and reduction of viral entry in polarized epithelial cells
46. Characterization of early stages in vaccinia virus membrane biogenesis: Implication of the 21-kDa and a newly identified 15-kDa envelope protein
47. Vaccinia virus A14L gene product is essential for assembly and attachment of viral crescents to virosomes
48. Structural maturation of the transmissible gastroenteritis coronavirus
49. Studies on the nature and location of the capsid polypeptides of vaccinia virions
50. Assembly of vaccinia virus: The second wrapping cisterna is derived from the trans-Golgi network
51. Novobiocin inhibits vaccinia virus replication by blocking virus assembly
52. Assembly of vaccinia virus: Effects of rifampin on the intracellular distribution of viral protein p65
53. Assembly of vaccinia virus: Incorporation of p14 and p32 into the membrane of the intracellular mature virus
54. Fine structure of the vaccinia virus gene encoding the precursor of the major core protein 4a
55. Proteolytic maturation of vaccinia virus core proteins: Identification of a conserved motif at the N termini of the 4b and 25K virion proteins
56. The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: A degenerate conserved cleavage motif within core proteins
57. Immunolocalization of vaccinia virus structural proteins during virion formation
58. Differential utilization of a conserved motif for the proteolytic maturation of vaccinia virus proteins
59. Physical and molecular genetic analysis of the multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein
60. Vaccinia virus core protein VP8 is required for virus infectivity but not for core protein processing or for INV and EEV formation
61. Vaccinia virions lacking core protein VP8 are deficient in early transcription
62. Mapping of the genes coding for the two major vaccinia virus core polypeptides
63. Vaccinia virus WR gene A5L is required for morphogenesis of mature virions
64. Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis
65. Biosynthesis and post-translational cleavage of vaccinia virus structural protein VP8
66. Inducer-dependent conditional-lethal mutant animal viruses
67. Vaccinia virus morphogenesis is interrupted when expression of the gene encoding an 11-kilodalton phosphorylated protein is prevented by the Escherichia coli lac repressor
68. Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin
69. Targeting of a multicomponent transcription apparatus into assembling vaccinia virus particles requires RAP94, an RNA polymerase-associated protein